The latest biotech news

News and Trends 7 May 2025

Top biotech deals of April 2025

Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and drug delivery.

May 7, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 28 Apr 2025

U.S. budget cuts: what is the impact on therapeutic research?

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs and lawsuits.

April 28, 2025 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 16 Apr 2025

Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases

Learn about Brink Tx as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

April 16, 2025 - 7 minutesmins - By Jules Adam

News and Trends 15 Apr 2025

The AI race in biotech: Is Europe falling behind the US and China?

Find out why Europe has fallen behind the U.S. and China in the AI race in biotech and what it needs to do to catch up.

April 15, 2025 - 9 minutesmins - By Willow Shah-Neville

News and Trends 9 Apr 2025

The biotech job market in 2025: Still in survival mode?

The biotech job market has been tough the last few years but is it getting better? Delve into the industry’s job market in 2025.

April 9, 2025 - 7 minutesmins - By Jules Adam

News and Trends 4 Apr 2025

Developing drugs from outer space: Exobiosphere raises €2 million

Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round.

April 4, 2025 - 7 minutesmins - By Jules Adam

News and Trends 2 Apr 2025

Top biotech deals of March 2025

Learn about the top biotech deals of March 2025. Small molecules, bispecific antibodies, and protein therapies were all part of major collaborations.

April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 31 Mar 2025

AstraZeneca bets on Asia: a surge of deals in March amid fraud probe

AstraZeneca has vowed to spend over $10 billion in Asia, particularly in China, to build Beijing into an R&D hub amid probe into fraud scandals.

March 31, 2025 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 25 Mar 2025

AbbVie and Genmab: Can a legal battle break a billion-dollar bond?

As AbbVie accuses Genmab of unlawfully using proprietary ADC technology, find out about their collaboration and the dispute opposing them.

March 25, 2025 - 5 minutesmins - By Jules Adam

News and Trends 24 Mar 2025

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

The first RIPTAC has just hit the clinic. Learn about this new technology that is being developed by Halda Therapeutics.

March 24, 2025 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 21 Mar 2025

Depression drug trials are failing—and placebos are to blame

In this article, we examine recent clinical trial failures and discuss potential pathways forward for antidepressant drug research.

March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 10 Mar 2025

23andMe: the collapse of a genomics giant

23andMe was once worth $6 billion and is now a penny stock. Layoffs, data breaches, and mass resignations plagued the genomics giant. How did it all unfold?

March 10, 2025 - 8 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Top biotech deals of April 2025

U.S. budget cuts: what is the impact on therapeutic research?

Beyond CRISPR: Brink Therapeutics raises $4 million with engineered recombinases

The AI race in biotech: Is Europe falling behind the US and China?

The biotech job market in 2025: Still in survival mode?

Developing drugs from outer space: Exobiosphere raises €2 million

Top biotech deals of March 2025

AstraZeneca bets on Asia: a surge of deals in March amid fraud probe

AbbVie and Genmab: Can a legal battle break a billion-dollar bond?

First-ever RIPTAC enters clinic: all you need to know about this new cancer approach

Depression drug trials are failing—and placebos are to blame

23andMe: the collapse of a genomics giant

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!